XLRN - Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q4 2020 Results - Earnings Call Transcript
Acceleron Pharma Inc. (XLRN) Q4 2020 Results Conference Call February 25, 2021 05:00 PM ET Company Participants Jamie Bernard - Director of Investor Relations Habib Dable - Chief Executive Officer Kevin McLaughlin - Chief Financial Officer Jay Backstrom - Head of Research and Development Sujay Kango - Chief Commercial Officer Todd James - Senior Vice President of Corporate Affairs and Investor Relations Conference Call Participants Yaron Werber - Cowen Carter Gould - Barclays Nicole Gabreski - Piper Sandler Eric Joseph - JP Morgan Edward White - HC Wainwright Yigal Nochomovitz - Citi Kennen MacKay - RBC Capital Markets Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Acceleron Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, this conference call
For further details see:
Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q4 2020 Results - Earnings Call Transcript